InvestorsHub Logo
Followers 84
Posts 4945
Boards Moderated 1
Alias Born 12/04/2009

Re: Ibcnu post# 21965

Saturday, 04/29/2017 11:31:50 AM

Saturday, April 29, 2017 11:31:50 AM

Post# of 36292
Great. I too long here since 3 years. I differ with post on company communication. Company has provided already good news if we see carefully. If they have good products in market, then people will realize and stocks can go for stable nice position. I saw couple of stocks went very high without any major news and exploded on final mega news. I am still here ling term.

Having obtained U.S. FDA 510(k) Class II approval for its iTBra technology, CI has conducted clinical trials in the U.S. with its newly developed scalable product, which demonstrates greatly improved outcomes, beyond historical product results. CI’s predictive analytic artificial intelligence (AI) based technology now demonstrates 80%+ accuracy with a two-hour wear when compared with the original trials which required 48-hour wear and achieved 74% accuracy. CI and CA expect this greatly improved performance to support the use of the 510(k) approval to launch the technology and products into regulated countries in the near term.

On top of that they are preparing for License and Cooperation Agreement with Asia market.

CI has entered into a License and Cooperation Agreement Cyrcadia Asia, Ltd. (CA), a newly formed company in Hong Kong which will serve as the base for the Asia market launch of CI’s proprietary iTBraTM technology expected to commence in late 2017 or early 2018 under the global CI brand of Cyrcadia Health.

http://www.wave3.com/story/35254855/cyrcadia-inc-prepares-itbratm-product-launch-and-expands-strategic-operations-in-asia